Clinhope and K&C MEDICAL were originally responsible for different professional services in the CRO (commissioned clinical research) sector. With mutual consensus and tacit understanding, they announced that they will cooperate as preferential partners at the end of 2022. In the future, they will target domestic and foreign biotechnology markets and new innovations. The company is committed to business promotion and professional service provision.

Clinhope Consulting Co., Ltd. was established in 2016. It mainly provides domestic drug and medical device clinical regulation analysis and test execution and other related services. In 2020, it will set up an office in Texas, USA, and in 2022 it will complete the Hong Kong Science and Technology Park HKSTP professional network partner; K&C MEDICAL Co., Ltd. was established in 2009, focusing on medical device regulations consultants, mainly providing consultation and implementation of medical device registration regulations for domestic and foreign medical device manufacturers. Up to now, more than 400 third-level medical device licenses and more than 800 QSDs have been completed. Certificate approval, especially in the registration of innovative medical devices, also has extensive experience and has completed more than 100 approvals.

In response to the rapid development and innovation of Taiwan's biotech and the global medical device industry, the close cooperation between the two parties will effectively integrate resources, improve R&D performance, and provide customers with more complete product evaluations to meet future economic benefits.

Please refer to the link: https://ctee.com.tw/industrynews/biomed/802596.html
Back to the top